Clinical Trials Logo

Uveal Neoplasms clinical trials

View clinical trials related to Uveal Neoplasms.

Filter by:
  • Available  
  • Page 1

NCT ID: NCT04960891 Available - Uveal Melanoma Clinical Trials

A Cohort IND Expanded Access Program for Supporting Patient Access to Tebentafusp

Non Applicable
Start date: n/a
Phase:
Study type: Expanded Access

This Expanded Access Program aims to: 1. Provide access to tebentafusp for mUM patients. 2. Provide access to tebentafusp for patients, who were on the control arm of the randomized controlled Phase II trial (IMCgp100-202) and were unable to crossover during the specified window. 3. Ensure that patients, who are benefiting from tebentafusp treatment while participating in an ongoing Immunocore sponsored clinical study (e.g., IMCgp100-102 or IMCgp100-201), may continue tebentafusp treatment on this Programme once the ongoing trial has met all of its key primary and secondary objectives.